![PHGE - BIOMX INC](https://storage.googleapis.com/iexcloud-hl37opg/api/logos/PHGE.png)
-
BIOMX INC NYSE MKT LLC:PHGE BiomX is a clinical-stage biotechnology company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as inflammatory bowel disease, primary sclerosing cholangitis, cystic fibrosis, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets.
Location: | Website: www.biomx.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
24.13M
Cash
31.61M
Avg Qtr Burn
-8.689M
Short % of Float
0.17%
Insider Ownership
11.68%
Institutional Own.
52.31%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|